Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gregson

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
European Heart Journal|August 23, 2021
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trialStuart J Pocock, João Pedro Ferreira, John Gregson, et al.
Journal of the American College of Cardiology|June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical ImprovementsAudinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
Circulation|June 24, 2022
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular DiseaseDorien M Kimenai, Leah Pirondini, John Gregson, et al.
European Journal of Heart Failure|January 17, 2020
Predictors of sudden cardiac death in high-risk patients following a myocardial infarctionKieran F Docherty, João Pedro Ferreira, Abhinav Sharma, et al.
Trials|July 27, 2022
The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of strokeSuk Fun Cheng, Twan J van Velzen, John Gregson, et al.
Clinical Cardiology|November 1, 2022
Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registryAkshay Bagai, Faeez M Ali, John Gregson, et al.
Archives of Disease in Childhood|July 9, 2017
A community-based motivational personalised lifestyle intervention to reduce BMI in obese adolescents: results from the Healthy Eating and Lifestyle Programme (HELP) randomised controlled trialDeborah Christie, Lee Duncan Hudson, Sanjay Kinra, et al.
BMJ Open|February 17, 2018
Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)Monica Panca, Deborah Christie, Tim J Cole, et al.
Stroke|September 25, 2019
Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting StudyMandy D Müller, John Gregson, Dominick J H McCabe, et al.
ESC Heart Failure|March 8, 2022
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathyBrian P Halliday, Ruth Owen, John Gregson, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
European Heart Journal|August 23, 2021
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trialStuart J Pocock, João Pedro Ferreira, John Gregson, et al.
Journal of the American College of Cardiology|June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical ImprovementsAudinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
Circulation|June 24, 2022
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular DiseaseDorien M Kimenai, Leah Pirondini, John Gregson, et al.
European Journal of Heart Failure|January 17, 2020
Predictors of sudden cardiac death in high-risk patients following a myocardial infarctionKieran F Docherty, João Pedro Ferreira, Abhinav Sharma, et al.
Trials|July 27, 2022
The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of strokeSuk Fun Cheng, Twan J van Velzen, John Gregson, et al.
Clinical Cardiology|November 1, 2022
Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registryAkshay Bagai, Faeez M Ali, John Gregson, et al.
Archives of Disease in Childhood|July 9, 2017
A community-based motivational personalised lifestyle intervention to reduce BMI in obese adolescents: results from the Healthy Eating and Lifestyle Programme (HELP) randomised controlled trialDeborah Christie, Lee Duncan Hudson, Sanjay Kinra, et al.
BMJ Open|February 17, 2018
Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)Monica Panca, Deborah Christie, Tim J Cole, et al.
Stroke|September 25, 2019
Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting StudyMandy D Müller, John Gregson, Dominick J H McCabe, et al.
ESC Heart Failure|March 8, 2022
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathyBrian P Halliday, Ruth Owen, John Gregson, et al.
Pageof 12